Is the FDA’s Fast-Track AI Rollout a Leap Toward Smarter Healthcare—or a Risky Gamble?
The FDA is racing to bring artificial intelligence into the heart of its operations, and the stakes couldn’t be higher. On Tuesday, the Food and Drug Administration will officially launch Elsa, its new agency-wide AI tool designed to transform regulatory reviews and relieve time-strapped staff. Commissioner Marty Makary is
